Recursion Pharmaceuticals, Inc.

Ticker

RXRX

ISIN

US75629V104

Price

USD 8.84

Change Today

+0.05 / 0.569 %

Price 1 year ago

4.79 / 84.551 %

Market Capitalization

2,337,225,472.00

52 Week Low

5.09

52 Week High

15.86

200 Day Moving Average

9.25

50-day Moving Average

9.95


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Sector

Healthcare

Industry

Biotechnology

Country

United States

Exchange

NMS

Earnings Per Share

-1.307

P/E Ratio

-

Debt/Equity Ratio

13.45

Beta

-

City

Salt Lake City

Address

41 South Rio Grande Street

Zip

84101

Ebitda

-236,120,992.00

-

Enterprise to Ebitda

-7.21

Enterprise Value

1,703,508,352.00

Target Price

17.60

Estimated Price

-

Book Value

2.53

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
300181.SZ ZHEJIANG JOLLY PHA -0.65
600866.SS STAR LAKE BIOSCIENCE CO INC Z -0.54
IMU.AX IMUGENE FPO -0.54
600200.SS JIANGSU WUZHONG PHARMACEUTICAL -0.46
300204.SZ STAIDSON (BEIJING) -0.30
2137.HK BRII-B -0.20
ALPHA.PA PHARNEXT -0.10
300009.SZ ANHUI ANKE BIOTECH 0.04
1873.HK VIVA BIOTECH 0.05
TRX.L TISSUE REGENIX GROUP PLC 0.10
2370.T MEDINET CO LTD 0.10
1530.HK 3SBIO 0.15
300497.SZ JIANGXI FUSHINE PH 0.16
2269.HK WUXI BIO 0.19
1177.HK SINO BIOPHARM 0.24
002252.SZ S/H RAAS BLOOD PRO 0.26
300363.SZ PORTON PHARMA SOLU 0.32
300147.SZ XIANGXUE PHARMACEU 0.38
0775.HK CKLIFE SCIENCES 0.40
AKBA Akebia Therapeutics, Inc. 0.41
1801.HK INNOVENT BIO 0.42
TMBR Timber Pharmaceuticals, Inc. 0.46
600201.SS JINYU BIO-TECHNOLOGY CO LTD 0.52
300122.SZ CHONGQING ZHIFEI B 0.55
002007.SZ HUALAN BIOLOGICAL 0.55
ATHX Athersys, Inc. 0.57
BLUE bluebird bio, Inc. 0.60
DNA Ginkgo Bioworks Holdings, Inc. 0.81

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
ALPHA.PA PHARNEXT Issy-les-Moulineaux France EUR PAR 2.86 -0.65 40 https://www.pharnext.com
1177.HK SINO BIOPHARM Wan Chai Hong Kong HKD HKG 0.48 17.58 25579 https://www.sinobiopharm.com
0775.HK CKLIFE SCIENCES Tai Po Hong Kong HKD HKG 0.40 32.46 1855 https://www.ck-lifesciences.com
DNA Ginkgo Bioworks Holdings, Inc. Boston United States USD NYQ -1.24 641 https://www.ginkgobioworks.com
002252.SZ S/H RAAS BLOOD PRO Shanghai China CNY SHZ 0.21 19.62 2966 https://www.raas-corp.com
002007.SZ HUALAN BIOLOGICAL Xinxiang China CNY SHZ 0.03 19.25 2927 https://www.hualanbio.com
600200.SS JIANGSU WUZHONG PHARMACEUTICAL Suzhou China CNY SHH 0.56 -710.43 https://www.600200.com
600866.SS STAR LAKE BIOSCIENCE CO INC Z Zhaoqing China CNY SHH 0.35 21.35 2608 https://www.starlake.com.cn
TRX.L TISSUE REGENIX GROUP PLC Garforth United Kingdom GBp LSE 1.40 -10.94 79 https://www.tissueregenix.com
2269.HK WUXI BIO Wuxi China HKD HKG 0.91 85.17 9864 https://www.wuxibiologics.com
IMU.AX IMUGENE FPO Sydney Australia AUD ASX 2.28 -30.30 https://www.imugene.com
600201.SS JINYU BIO-TECHNOLOGY CO LTD Hohhot China CNY SHH 0.31 18.76 1580 https://www.jinyu.com.cn
TMBR Timber Pharmaceuticals, Inc. Basking Ridge United States USD ASE 0.19 5 https://www.timberpharma.com
300181.SZ ZHEJIANG JOLLY PHA Huzhou China CNY SHZ 0.10 18.50 2132 https://www.zuoli.com
CLVS Clovis Oncology, Inc. Boulder United States USD NMS 0.49 -3.78 413 https://www.clovisoncology.com
ATHX Athersys, Inc. Cleveland United States USD NCM -1.30 -0.60 104 https://www.athersys.com
VTGN VistaGen Therapeutics, Inc. South San Francisco United States USD NCM 1.06 0.75 36 https://www.vistagen.com
300009.SZ ANHUI ANKE BIOTECH Hefei China CNY SHZ 0.38 19.32 https://www.ankebio.com
300122.SZ CHONGQING ZHIFEI B Chongqing China CNY SHZ 0.77 11.89 4800 https://www.zhifeishengwu.com
2370.T MEDINET CO LTD Tokyo Japan JPY JPX 1.34 -2.69 92 https://www.medinet-inc.co.jp
2137.HK BRII-B Beijing China HKD HKG -5.41 113 https://www.briibio.com
1530.HK 3SBIO Shenyang China HKD HKG 0.84 6.75 5292 https://www.3sbio.com
1801.HK INNOVENT BIO Suzhou China HKD HKG -0.31 -14.04 5568 https://www.innoventbio.com
300497.SZ JIANGXI FUSHINE PH Jingdezhen China CNY SHZ 0.14 35.19 1849 https://www.fushine.cn
300147.SZ XIANGXUE PHARMACEU Guangzhou China CNY SHZ 0.59 374.63 3378 https://www.xphcn.com
BLUE bluebird bio, Inc. Cambridge United States USD NMS 1.38 -0.35 518 https://www.bluebirdbio.com
300204.SZ STAIDSON (BEIJING) Beijing China CNY SHZ 0.16 -27.06 873 https://www.staidson.com
AKBA Akebia Therapeutics, Inc. Cambridge United States USD NGM 1.47 -0.16 426 https://www.akebia.com
1873.HK VIVA BIOTECH Shanghai China HKD HKG 0.95 15.94 2127 https://www.vivabiotech.com.cn
300363.SZ PORTON PHARMA SOLU Chongqing China CNY SHZ -0.36 30.90 4158 https://www.porton.cn
VLON Vallon Pharmaceuticals Inc. Philadelphia United States USD NCM -1.15 -0.24 2 https://www.vallon-pharma.com
SRNE Sorrento Therapeutics, Inc. San Diego United States USD NCM 2.17 -2.59 799 https://www.sorrentotherapeutics.com
NVAX Novavax, Inc. Gaithersburg United States USD NMS 1.58 -2.58 1541 https://www.novavax.com
300759.SZ PHARMARON BEIJING Beijing China CNY SHZ 0.28 49.23 14923 https://www.pharmaron.com
300404.SZ BOJI MEDICAL & TEC Guangzhou China CNY SHZ -0.10 63.41 989 https://www.bojicro.com
RIGL Rigel Pharmaceuticals, Inc. South San Francisco United States USD NMS 1.66 -2.33 165 https://www.rigel.com
688180.SS SHANGHAI JUNSHI BIOSCIENCES CO Shanghai China CNY SHH 0.24 -39.92 2805 https://www.junshipharma.com
600161.SS BEIJING TIANTAN BIOLOGICAL PROD Beijing China CNY SHH 0.02 23.29 3933 https://www.tiantanbio.com
9939.HK KINTOR PHARMA-B Suzhou China HKD HKG -0.77 -5.99 316 https://www.kintor.com.cn
VERU Veru Inc. Miami United States USD NCM -0.41 -41.18 252 https://www.verupharma.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.